معرفی
Thomas Gal serves as Professor of Otolaryngology at the University of Kentucky, holding dual leadership roles as Director of Veterans Affairs for Otolaryngology and active membership in both the Markey Cancer Center/Cancer Research Priority Initiative and Translational Oncology Research Program.
His educational foundation includes a Doctor of Medicine from Thomas Jefferson University (1993), Residency at University of South Florida (1999), and Master of Public Health with Postdoctoral Fellowship from University of Washington (2003).
Dr. Gal's research centers on Outcomes Research in Head and Neck Oncology and Reconstruction, with documented expertise in free tissue grafts (88% fingerprint match), neck reconstruction (49%), laryngectomy (57%), and laryngeal cancer (39%). His work directly supports UN Sustainable Development Goal 3 (Good Health and Well-being) through surgical innovation and oncology advancements.
Recent publications (2021-2024) reveal three dominant research trajectories: 1) Microvascular reconstruction techniques (supraclavicular/posterior tibial flaps), 2) Facial trauma management (NOE fractures, frontal sinus repairs), and 3) Collaborative oncology trials (breast/thyroid cancer). These reflect his dual focus on surgical precision and evidence-based outcomes.
His major grant involvement includes the IRX-2 2015A Phase 2 trial (2016-2023) for oral cavity squamous cell carcinoma, demonstrating sustained commitment to translational oncology. Current institutional affiliations position him at the intersection of Veterans Affairs care, cancer research, and surgical innovation through the Markey Cancer Center network.
